Innovators in life sciences at companies and universities often collaborate and conduct research under a joint research agreement (JRA). The Cooperative Research and Technology Enhancement Act of 2004 (the “CREATE Act”) was...more
3/11/2021
/ Collaboration ,
CREATE Act ,
Innovation ,
Life Sciences ,
Obviousness-Type Double Patenting (ODP) ,
Patent Applications ,
Patent Portfolios ,
Patents ,
Prior Art ,
Proposed Rules ,
Terminal Disclaimer ,
USPTO